Literature DB >> 16781694

Induction of CD8+ T cell responses through targeting of antigen to Dectin-2.

Robert W Carter1, Clare Thompson, Delyth M Reid, Simon Y C Wong, David F Tough.   

Abstract

Targeted delivery of antigens to dendritic cells (DC) can be used to optimise immunisation. We investigated whether the efficacy with which immune responses are induced can be improved by targeting Ags to a C-type lectin receptor, Dectin-2. When anti-Dectin-2 mAbs were injected s.c., mAb binding was detected on a low percentage of DC in the draining lymph node. Ag conjugated to anti-Dectin-2 mAbs was presented efficiently to CD8+ T cells in vivo and elicited CD8+ T cell responses at low doses where free Ag failed to induce a response. The results reveal Dectin-2 as a potential targeting molecule for immunisation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781694     DOI: 10.1016/j.cellimm.2006.05.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  18 in total

1.  Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

Authors:  Eynav Klechevsky; Anne-Laure Flamar; Yanying Cao; Jean-Philippe Blanck; Maochang Liu; Amy O'Bar; Olivier Agouna-Deciat; Peter Klucar; Luann Thompson-Snipes; Sandra Zurawski; Yoram Reiter; A Karolina Palucka; Gerard Zurawski; Jacques Banchereau
Journal:  Blood       Date:  2010-06-07       Impact factor: 22.113

Review 2.  Directing dendritic cell immunotherapy towards successful cancer treatment.

Authors:  Rachel Lubong Sabado; Nina Bhardwaj
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 3.  Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention.

Authors:  T W H Flinsenberg; E B Compeer; J J Boelens; M Boes
Journal:  Clin Exp Immunol       Date:  2011-05-11       Impact factor: 4.330

Review 4.  Experimental models to investigate the function of dendritic cell subsets: challenges and implications.

Authors:  D G Hancock; T V Guy; E Shklovskaya; B Fazekas de St Groth
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

5.  Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.

Authors:  Luciene Lopes; Marie Dewannieux; Uzi Gileadi; Ranbir Bailey; Yasuhiro Ikeda; Christopher Whittaker; Matthew P Collin; Vincenzo Cerundolo; Mizuki Tomihari; Kiyoshi Ariizumi; Mary K Collins
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

Review 6.  The Dectin-2 family of C-type lectins in immunity and homeostasis.

Authors:  Lisa M Graham; Gordon D Brown
Journal:  Cytokine       Date:  2009-08-07       Impact factor: 3.861

Review 7.  C-type lectin receptors orchestrate antifungal immunity.

Authors:  Sarah E Hardison; Gordon D Brown
Journal:  Nat Immunol       Date:  2012-08-21       Impact factor: 25.606

8.  Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.

Authors:  David Sancho; Diego Mourão-Sá; Olivier P Joffre; Oliver Schulz; Neil C Rogers; Daniel J Pennington; James R Carlyle; Caetano Reis e Sousa
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 9.  Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology.

Authors:  Xiaofei Yu; Chunqing Guo; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2015-06-17       Impact factor: 6.242

10.  Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection.

Authors:  Matthew J Robinson; Fabiola Osorio; Marcela Rosas; Rui P Freitas; Edina Schweighoffer; Olaf Gross; J Sjef Verbeek; Jürgen Ruland; Victor Tybulewicz; Gordon D Brown; Luis Ferreira Moita; Philip R Taylor; Caetano Reis e Sousa
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.